Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises on the sale of Snabboteket
Mandate

Vinge advises on the sale of Snabboteket

November 24, 2015

Vinge has advised the sellers in connection with the sale of Snabboteket AB to Apoteket AB (publ). Snabboteket sells drugs without prescription and self-care products in small packages for inter alia the hotel and travel markets. State owned Apoteket is Sweden’s leading pharmacy operator. Snabboteket has been a Vinge Growth client since the company was founded in 2010.

From Vinge, Kristian Ford has advised the sellers of Snabboteket.

Related

Vinge advises Cantargia in connection with the sale of immunology program CAN10

 Vinge advises Cantargia AB (publ) in connection with the sale of its early-clinical stage IL1RAP immunology program CAN10 to the Japanese healthcare company Otsuka Pharmaceutical.
July 21, 2025

Vinge has assisted PulPac in connection with it obtaining a €20 million financing from the European Investment Bank

 Vinge has assisted Gothenburg-based sustainable packaging technology company PulPac in connection with it obtaining a €20 million (around 220 million Swedish kronor) financing from the European Investment Bank (EIB).
July 18, 2025

Vinge has advised Behold Ventures in the fundraising of Behold Ventures’ first-time fund

Behold Ventures held its final closing on 27 June 2025, thereby securing investor commitments to its first-time fund amounting to approximately SEK 550 million from an international investor base, comprising the European Investment Fund (EIF), among others.
July 10, 2025